We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc

Delisted

ALPN was delisted on the 17th of May, 2024.

47 hedge funds and large institutions have $58.1M invested in Alpine Immune Sciences Inc in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $55.4M → $58.1M (+$2.69M)

6% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 16

19% less funds holding

Funds holding: 5847 (-11)

77% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 13

Holders
47
Holders Change
-11
Holders Change %
-18.97%
% of All Funds
1.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
15
Reduced
16
Closed
13
Calls
Puts
Net Calls
Net Calls Change

ALPN Hedge Fund Activity: Q2 2016 in Review

47 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q2 2016, worth a combined $58.1M — up 4.9% from $55.4M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of ALPN and 3 opened new positions — a net loss of 10 holders — while 16 trimmed existing stakes and 15 added.

The largest buyer was BVF Inc, adding an estimated $1.68M. The largest seller was RA Capital Management, exiting entirely with an estimated $2.56M sold.

  • 47 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q2 2016, down from 58 in Q1 2016.
  • Funds reported $58.1M of Alpine Immune Sciences Inc stock for Q2 2016, up 4.9% quarter-over-quarter.
  • 3 funds opened new Alpine Immune Sciences Inc positions in Q2 2016 and 13 closed out, a net change of -10 holders.
  • The largest Alpine Immune Sciences Inc buyer in Q2 2016 was BVF Inc, an estimated $1.68M added.
  • The largest Alpine Immune Sciences Inc seller in Q2 2016 was RA Capital Management, an estimated $2.56M sold.

Based on aggregated 13F filings for Q2 2016.